 |
Partners' Directory |
| Home Search Join the Partnership Login | |
| Contact | General | Specializations in Countries | Contribution to the Global Plan | Declaration |
View this partner's profile
Organization Contact Information | |
| Name: | Ambassadors of change, NGO |
| Street 1: | Kenyatta Avenue |
| Street 2: | |
| City: | Nakuru |
| Province: | Rift Valley |
| Post Code: | 20100 |
| Country: | Kenya |
| Phone: | +254727611175 |
| Email: | paulmoseskirobia@yahoo.com |
| Web Site: | |
|
|
||||||||||||||||||||||||||||
General Information | |
| Board Constituency: | Developing Country NGO |
| Organization Type - Primary: | Non-Governmental Organization |
| Organization Type - Secondary: | Community-Based Organization (CBO) |
| Is your organization legally registered in your country: | Yes |
| Organization Reach: | National |
| Organization Description: | |
| PROMOTING HEALTH RIGHTS, ADVOCACY FOR STRENGTHENED HEALTH SYSTEMS AND HEALTH WORKFORCE, ACCESS TO MEDICINES.REDUCTION, ELIMINATION OF COMMUNICABLE AND NON-COMMUNICABLE DISEASES,RESPONSE TO IMPACT OF RAPID URBANIZATION ON HEALTH WHILE DEVELOPING EFFECTIVE STRATEGIES TO ADDRESS CRITICAL ISSUES POSING CHALLENGES TO PUBLIC HEALTH E.G OVERCROWDING, SLUMS FORMATIONS, INSECURITY, POOR SANITATION, TB/HIV CO- INFECTIONS, LACK OF ACCESS TO HEALTH CARE SERVICES, AND INCREASED POVERTY. TB REMAINS NO ONE KILLER DISEASE IN THE GLOBAL SOUTH COMPOUNDED BY MDR-TB, HIGH HIV PREVALENCE , AND WEAK HEALTH PROGRAMS AND SYSTEMS HENCE THE URGENT NEED TO ADVOCATE FOR INCREASED FUNDING FOR EFFECTIVE RESPONSE TO THE DISEASE AT GRASSROOTS LEVELS THROUGH OUTREACHES,MODERN COMMUNICATION TECHNOLOGIES AND MEDIA STRATEGY TO DISSEMINATE ACCURATE INFORMATION ON PREVENTIVE METHODS, IMPROVED DIAGNOSIS AND TREATMENT AND INCREASED CAPACITY AMONG HEALTH PROVIDERS ON DIAGNOSTICS AND TREATMENT. ADVOCACY FOR ALTERNATIVE TB DRUGS TO BE USED FOR LESSER PERIOD BY TB PATIENTS. CURRENTLY, ENGAGED IN DEFAULTER TRACING,COMMUNITY MOBILIZATION TO TEST TB, SIGNS AND OF SYMPTOMS FOR EARLY INITIATION TO TREATMENT |
|
| Total number of staff in your organization: | 11 - 25 |
| Number of full-time staff who are directly involved with TB: | 1 - 5 |
| Number of part-time staff who are directly involved with TB: | 0 |
| Number of volunteers who are directly involved with TB: | 26 - 50 |
| What is your organization's annual budget (USD) dedicated to TB? | $5,001-$10,000 |
| How did you hear about the Stop TB Partnership: | Other partners |
| Why do you wish join the Stop TB Partnership: | Involvement in Stop TB Working Groups |
| Are you a member of a Stop TB national partnership: | No |
| Are you in contact with your national TB programme: | Yes |
| Please tell us how your organization is contributing to your country's national TB control plan: | |
| SURVEILLANCE , MONITORING TRENDS,PLANNING AND PROGRAMMING AND ADVOCACY | |
Geographical Reach | |
| Which country is your headquarters located in: | Kenya |
| Which WHO region is the main focus of your work: | African |
| Which countries do you do operate in: (This includes countries you are conducting activities in) |
Kenya |
Specializations | |
|
Advocacy, communication and social mobilization Research and Development |
Specializations in Countries | |
| Advocacy, communication and social mobilization | Kenya |
Contribution | |
| Please tell us how your organization will contribute to the Global Plan to Stop TB by briefly describing its involvement in any of the areas of work listed below: | |
|
DOTS Expansion and Enhancement: ADVOCACY FOR TB TREATMENT BEYOND DOTS Drug-Resistant TB: PROMOTING COMMUNITY KNOWLEDGE ON TB SYMPTOMS, NEED FOR EARLY TREATMENT AND ADHERENCE TO MEDICATION TO REDUCE CASES OF Drug-Resistant TB TB-HIV: Reduction of stigma associated with the two diseases as barrier to testing and treatment including advocacy for integrated health care delivery in both public ,private sectors and workplaces Laboratory Strengthening: Ensuring essential equipments are available, accessible both in rural and urban settings to diagnose TB cases and detect MDR-TB including proper training among clinicians and data collection , storage and analysis for improved programming and treatment New Diagnostics: Diagnostics on TB drug resistance among patients particularly HIV Positives and new diagnostics that goes beyond x-rays and sputum tests. New TB Drugs: combination of drugs to reduce fatigue among patients and enhance adherence. Operational Research: Assessment of impact of integration of TB/HIV prevention,treatment and developing mechanisms aimed at addressing the gaps. |
|
Declaration | |
| Declaration of interests: No conflicts of interest were delacred. | |
| Application date: | November 16, 2011 |
| Last updated: | November 16, 2011 |